Affiliation:
1. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322
Abstract
ABSTRACT
We developed a novel real-time PCR assay to detect
Klebsiella pneumoniae
carbapenemases (KPCs) and used this assay to screen clinical isolates of
K. pneumoniae
and
Klebsiella oxytoca
for the presence of
bla
KPC
genes. The TaqMan real-time PCR assay amplified a 399-bp product from the
bla
KPC
gene. The amplicon was designed so that the genes for isoenzymes KPC-1, -2, and -3 could be easily distinguished by subsequent restriction digestion of the amplicon with the enzymes BstNI and RsaI. The assay was validated with reference strains obtained from the Centers for Disease Control and Prevention that contained each of the three described isoenzymes and 69 extended-spectrum β-lactamase-producing clinical isolates (39
K. pneumoniae
and 30
K. oxytoca
isolates). Subsequently, the
bla
KPC
PCR assay was used to confirm the presence of
bla
KPC
genes in any meropenem-resistant
Klebsiella
spp. The PCR assay detected
bla
KPC
in all of the reference strains, in 6 of 7 meropenem-resistant isolates, and in 0 of 62 meropenem-susceptible clinical isolates. The PCR assay was then used to confirm the presence of
bla
KPC
in an additional 20 meropenem-resistant isolates from 16 patients. Restriction digestion of the PCR amplicons identified two
bla
KPC
gene variants in our patient population: 9 isolates with C and 17 with T at nucleotide 944, consistent with
bla
KPC-2
and
bla
KPC-3
, respectively. The real-time PCR assay is a rapid and accurate method to detect all KPC isoenzymes and was useful in documenting the presence and dissemination of KPC-producing strains in our patient population.
Publisher
American Society for Microbiology